- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05133271
Prediction of Maternal Arterial Hypotension After Spinal Anesthesia by Passive Leg Raise Test. (EDLIDL)
Assessment of the Value of Passive Leg Raising (PLR) in Predicting the Onset of Maternal Arterial Hypotension and Norepinephrine Requirements After Spinal Anesthesia for Scheduled Cesarean Section.
Spinal anesthesia for cesarean section is associated with a high incidence of low blood pressure. However, the pathophysiology of this arterial hypotension is not unequivocal and could involve, in addition to drug vasoplegia, a mechanical cause linked to lower caval compression or even true or relative hypovolemia. Passive leg raise test has been proposed in an attempt to identify parturients who are more likely to develop low blood pressure after spinal anesthesia. Nevertheless, the data available on this volume expansion test to predict hemodynamic variations after performing spinal anesthesia are still limited and few objective criteria have been described to predict this arterial hypotension.
The objective of the research is to study the hypothesis according to which the presence of hypovolaemia (true or relative) objectified by a positive passive leg raise test would cause hypotension more frequent and more marked in intensity.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Spinal anesthesia for cesarean section is associated with a high incidence of low blood pressure. However, the pathophysiology of this arterial hypotension is not unequivocal and could involve, in addition to drug vasoplegia, a mechanical cause linked to lower caval compression or even true or relative hypovolemia.
Passive leg raise test has been proposed in an attempt to identify parturients who are more likely to develop low blood pressure after spinal anesthesia. Nevertheless, the data available on this volume expansion test to predict hemodynamic variations after performing spinal anesthesia are still limited and few objective criteria have been described to predict this arterial hypotension.
The objective of the research is to study the hypothesis according to which the presence of hypovolaemia (true or relative) objectified by a positive passive leg raise test would cause hypotension more frequent and more marked in intensity.
Patients will have a clinical hemodynamic and echocardiographic evaluation, before performing the spinal anesthesia, before and after the passive leg raise test.
Then, the patients will benefit from a clinical hemodynamic evaluation during the preparation of the parturient in the operating room and finally after the completion of the spinal anesthesia and until the clamping of the umbilical cord.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75015
- Hôpital Necker-Enfants Malades
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult women admitted to Necker Enfants Malades hospital for scheduled cesarean section under spinal anesthesia
- Written informed consent
Exclusion Criteria:
- No health insurance
- Urgent cesarean
- Failure of spinal anesthesia
- Free and informed consent impossible to obtain (especially due to a language barrier)
- Severe cardiovascular or neurovascular comorbidities
- Contraindication to the PLR (intracranial hypertension, fractures of the pelvis and / or lower limbs, ...)
- Background of preeclampsia or eclampsia
- Severe fetal pathology
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Scheduled cesarean section
Patient with scheduled cesarean section under spinal anesthesia.
|
Clinical hemodynamic and echocardiographic evaluation in two stages T1 and T2, before performing the spinal anesthesia, carried out by a doctor different from the doctor in charge of the parturient in the operating room to ensure the blind hemodynamic results before the spinal anesthesia, in particular those of the passive leg raise test (PLR) :
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maternal arterial hypotension
Time Frame: Day 0
|
Maternal arterial hypotension following spinal anesthesia.
Maternal hypotension is defined as a drop in systolic blood pressure (SBP)> 20% of baseline.
|
Day 0
|
|
Positivity of passive leg raise test
Time Frame: Day 0
|
A positive passive leg raise test is defined as an increase in the Subaortic Flow Velocity Time Integral of 10% or more.
The increase in cardiac output is measured by a cardiac ultrasound.
|
Day 0
|
|
Positive passive leg raise test performance
Time Frame: Day 0
|
Performance of a positive passive leg raise test in predicting the onset of maternal arterial hypotension after spinal anesthesia.
Significant performance will be defined by sensitivity and specificity > 90%.
|
Day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total dose of norepinephrine
Time Frame: Day 0
|
Total dose of norepinephrine received during the procedure from the beginning of the spinal anesthesia injection up to umbilical cord clamping measured in micrograms.
|
Day 0
|
|
Onset of severe arterial hypotension
Time Frame: Day 0
|
Onset of severe arterial hypotension defined as a drop in systolic blood pressure greater than 30% of baseline.
|
Day 0
|
|
Onset of nausea and vomiting
Time Frame: Day 0
|
Onset of nausea and vomiting from the spinal anesthesia injection up to the end of the c-section.
|
Day 0
|
|
Occurrence of disturbances of consciousness
Time Frame: Day 0
|
Occurrence of consciousness alteration assessed by the Glasgow Coma Scale (from Teasdale G & Jennett B. Lancet 1974). Three aspects of behavior are measured independently: motor response, verbal response and eye opening. Each component has a number of grades starting with the most severe. The best ocular response has 4 grades; the best verbal response has 5 grades; the best motor response has 6 grades. Rating: the score of each component as well as the sum of the components are considered. The total score is out of 15 points; lower scores indicating more severe impairment. The lowest possible score is 3, indicating deep coma or death, and the highest possible score is 15, indicating a fully awake individual. |
Day 0
|
|
Occurrence of sedation and agitation
Time Frame: Day 0
|
Occurrence of sedation and agitation during the c-section assessed by the Richmond Agitation-Sedation scale (RASS). This score is based on the observation of the patient It has 10 stages ranging from +4 (combative patient) to -5 (patient who cannot be woken up). |
Day 0
|
|
Assessment of fetal well-being
Time Frame: Day 0
|
Evaluation of fetal well-being by fetal heartbeat, by the Apgar score at 1, 3 and 5 minutes of life, and study of the pH in the umbilical cord, a pH value <7.2 defines fetal distress.
|
Day 0
|
|
Quality of ultrasound images
Time Frame: Day 0
|
Assessment of obtaining views (parasternal long-axis view, parasternal short-axis view, apical 4-chamber view, subcostal). Interpretability of the measurements obtained. |
Day 0
|
|
Relative or absolute hypovolemia
Time Frame: Day 0
|
Describe the echocardiographic parameters reflecting the different physiopathological mechanisms at the origin of arterial hypotension secondary to spinal anesthesia of the parturient at the end of pregnancy. To note the parameters suggestive of relative or absolute hypovolaemia: inferior vena cava diameter < 8 mm; "kissing sign" of the left ventricle, defined as à end-systolic collapse of the left ventricle; E/A ratio < 1. |
Day 0
|
|
Right ventricle systolic or diastolic dysfunction
Time Frame: Day 0
|
Describe the echocardiographic parameters reflecting the different physiopathological mechanisms at the origin of arterial hypotension secondary to spinal anesthesia of the parturient at the end of pregnancy. Right ventricle systolic function: measurement of the TAPSE (tricuspid annular plane systolic excursion; presence of a paradoxical septal motion (yes/no). Right ventricle diastolic function: presence of right ventricle dilation defined as end-diastolic right ventricle area (EDRVA) / end-diastolic left ventricle area (EDLVA) > 0.6; "severe" dilatation is defined as a ratio > 1. |
Day 0
|
|
Left ventricle systolic and diastolic dysfunction
Time Frame: Day 0
|
Describe the echocardiographic parameters reflecting the different physiopathological mechanisms at the origin of arterial hypotension secondary to spinal anesthesia of the parturient at the end of pregnancy. Left ventricle systolic function: left ventricle ejection fraction (LVEF) - apical-4-chamber view - defined as LVEF = (EDLVA-ESLVA)/EDLVA Left ventricle shortening fraction (LVSF) - parasternal short-axis view - defined as LVSF = (EDLVA-ESLVA)/EDLVA MAPSE (mitral annular plane systolic excursion Left ventricle diastolic function: Mitral flow profile: E wave / A wave ratio Left atrium area (cm²) |
Day 0
|
|
Pericardial effusion
Time Frame: Day 0
|
Describe the echocardiographic parameters reflecting the different physiopathological mechanisms at the origin of arterial hypotension secondary to spinal anesthesia of the parturient at the end of pregnancy. Measurement of the size (in mm) of the pericardial effusion (left and right ventricles lateral walls). |
Day 0
|
|
Maternal comfort during the passive leg raising
Time Frame: Day 0
|
Assessment of the maternal comfort during the passive leg raising test with a numerical scale (from 0: maximal discomfort to 10: maximal comfort).
|
Day 0
|
|
Heart rate
Time Frame: Day 0
|
Association of increased up heart rate and total dose of neosynephrine at the end of the c-section.
|
Day 0
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Xavier Repessé, MD, Assistance Publique - Hôpitaux de Paris
- Study Director: Hawa Keita-Meyer, MD, PhD, Assistance Publique - Hôpitaux de Paris
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- APHP210937
- 2021-A01099-32 (Other Identifier: ID-RCB Number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean
-
Charite University, Berlin, GermanyCompletedCesarean Section Complications | Cesarean Delivery Affecting Newborn | Cesarean Delivery Affecting FetusGermany
-
Ataturk UniversityUnknownCesarean Section Complications | Cesarean Section; Complications, Wound, Dehiscence | Cesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
Assiut UniversityNot yet recruitingCesarean Section Complications | Cesarean Section Niche
-
Kutahya Health Sciences UniversityCompletedPregnancy | Cesarean Section | Elective Cesarean SectionTurkey (Türkiye)
-
Columbia UniversityNot yet recruitingDexmedetomidine | Postoperative Analgesia | Cesarean Delivery | Cesarean Delivery; Neuraxial Opioids | Clonidine | Spinal Anesthesia for Cesarean SectionUnited States
-
Recep Tayyip Erdogan University Training and Research...CompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Mansoura UniversityRecruitingCesarean Delivery | Spinal Anesthesia for Cesarean SectionEgypt
-
Ataturk UniversityCompletedCesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedPregnancy | Repeat Cesarean Section | Vaginal Births After CesareanUnited States
-
Uludag UniversityUnknownCesarean Section Complications | Cesarean Wound Disruption | Cesarean Wound; DehiscenceTurkey
Clinical Trials on Clinical hemodynamic and echocardiographic evaluation
-
IRCCS San RaffaeleCompletedHeart Failure | Echocardiography | Tricuspid RegurgitationItaly
-
University of BariErasme University Hospital; Centre Hospitalier Universitaire Saint PierreActive, not recruiting
-
Central Hospital, Nancy, FranceNot yet recruitingMyocarditis | Kawasaki Disease | Pediatric Inflammatory Multisystem SyndromeFrance
-
Konya City HospitalRecruitingNewborn Morbidity | Newborn ComplicationTurkey (Türkiye)
-
University Tunis El ManarCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedHemodialysis ComplicationTurkey (Türkiye)
-
Aristotle University Of ThessalonikiRecruitingCardiovascular Diseases | Heart Failure | Valvular Heart Disease | Biochemical DysfunctionGreece
-
Xiangjun YangUnknownAcute Myocardial Infarction | Heart Failure With Preserved Ejection Fraction | Predictor | PrognosisChina
-
University Hospital, ToulouseTerminatedStroke | Muscle Spasticity | Upper Extremity ParalysisFrance
-
Edwards LifesciencesCompleted